Table 2.
The known PITX3 mutations associated with cataracts (NM_005029.4).
| Nucleic acid change | Protein change | Positions | Types | Mode | Numbers | Clinical phenotypes | References | |
|---|---|---|---|---|---|---|---|---|
| 1 | c.38G > A | p.S13 N | Exon2 | Missense | AD, heterozygous | 2 | ADCC, glaucoma, peters abnormality | [25, 30] |
| 2 | c.640_656dup | p.G220PfsX95 | Exon4 | Frameshift | AD, heterozygous | 14 | ADCC, PPC, ASMD | [14–17, 19, 23, 25, 30] |
| 3 | c.650delG | p.G217AfsX91 | Exon4 | Frameshift | AD/AR | 2 | PPC; microphthalmia with severe developmental delay (AR) | [14, 18] |
| 4 | c.542delC | p.P181LfsX127 | Exon4 | Frameshift | AD, heterozygous | 1 | PPC | [21] |
| 5 | c.640_656del | p.A214RfsX42 | Exon4 | Frameshift | AD/AR | 2 | PSC; microphthalmia with corneal sclerosis (AR) | [22, 26] |
| 6 | c.573delC | p.S192AfsX117 | Exon4 | Frameshift | AD, heterozygous | 1 | ADCC, ASMD | [23] |
| 7 | c.608delC | p.A203GfsX106 | Exon4 | Frameshift | AD, heterozygous | 2 | ADCC, PSC, nystagmus | [24, 26] |
| 8 | c.582delC | p.I194MfsX115 | Exon4 | Frameshift | AD, de novo | 1 | ADCC, microphthalmia, developmental delay, autism | [25] |
| 9 | c.669delC | p.L225WfsX84 | Exon4 | Frameshift | AD/AR | 1 | ADCC; ASMD, sclerosing cornea (AR) | [25] |
| 10 | c.797_814del | p.S266_A271del | Exon4 | In-frame | AD, heterozygous | 1 | PSC | [27] |
| 11 | c.470−477dup | p.A160RfsX152 | Exon4 | Frameshift | AD, heterozygous | 1 | Nuclear cataract | [28] |
Note. AD: autosomal dominant inheritance; AR: autosomal recessive inheritance; de novo: newly identified mutation; ADCC: autosomal dominant congenital cataract; ASMD: anterior segment mesenchyme dysplasia; PPC: posterior polar cataract; PSC: posterior subcapsular cataract.